Concerning the stage of the disease, it has been reported that in the early stages of cancer, ROS promote cancer initiation by inducing base pair substitution mutations in pro-oncogenes such as Ras and tumor suppressor genes such as p53 [106]. The gene discussed is TP53; the disease is cancer.